-
Off-label use common, not always backed by data; Study says fewer doctors providing charity care; EDs report greater shortage on-call specialist coverage
-
-
Doctors recognize the importance of delivering news of brain death as well as possible thoroughly, taking as much time as necessary, conveying the information of irreversible loss of brain function clearly and at a level family members can absorb.
-
The United States is not ready to follow some European nations in presuming that deceased patients have consented to organ donation if they did not specifically opt out, according to the national Institute of Medicine (IOM). However, the need for donor organs calls for boosting efforts to increase donations, including using organs from patients whose deaths are determined by cardiac criteria.
-
Surveys of ethics committees have long shown that the greatest share (90%) of ethics committee consults in the United States pertain to end-of-life issues. But in one growing specialty, ethics consults are about almost nothing but end of life.
-
In a case described by a prosecutor as resembling a horror movie, the U.S. Food and Drug Administration (FDA) has received reports of adverse effects in patients who received human tissue grafts that were allegedly harvested from bodies in funeral homes without consent of families and, possibly, without being tested for infectious diseases as required by federal law.
-
-
Crusade (can rapid risk stratification of unstable Angina Patients Suppress Adverse Outcomes With Early Implementation Of The ACC/AHA Guidelines) is a large quality improvement initiative ...
-
Overall, clopidogrel plus aspirin was not significantly more effective than aspirin alone in reducing the rate of myocardial infarction, stroke, or death from cardiovascular disease.
-
Long-term, 48-week co-administration of Fenofibrate plus Ezetimibe was well tolerated and more efficacious than Fenofibrate in patients with mixed hyperlipidemia.
